Eli Lilly & Co. vs. Quoin Pharmaceuticals, Ltd. American Depositary Shares
LLY
Eli Lilly & Co.
$1149.36 -0.88%
VS QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares
$7.26 -7.75%
Eli Lilly & Co. (LLY) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| LLY | QNRX | |
|---|---|---|
| Market Cap | $1.03 trillion | $15.81 million |
| Revenue (TTM) | $79.67 billion | — |
| Net Income (TTM) | $26.71 billion | $-18,665,315 |
LLY leads on 2 of 2 size & scale factors.
Valuation
| LLY | QNRX | |
|---|---|---|
| P/E Ratio | 38.58 | — |
| Price / Book | 30.51 | 4.02 |
| Price / Sales | 12.97 | — |
QNRX leads on 1 of 1 valuation factors.
Profitability
| LLY | QNRX | |
|---|---|---|
| Net Margin | 33.53% | — |
| Return on Equity | 78.84% | -474.62% |
LLY leads on 1 of 1 profitability factors.
Dividend
| LLY | QNRX | |
|---|---|---|
| Dividend Yield | 0.60% | — |
| Payout Ratio | 23.23 | — |
LLY and QNRX split the dividend factors evenly.
Risk & Sentiment
| LLY | QNRX | |
|---|---|---|
| Short Interest | 1.29% | 4.83% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, QNRX overview, QNRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.